Distinguished Professor Lyn Griffiths AM is a global leader in translational genomics whose contributions bridge discovery and clinical application. She pioneered Australia’s first accredited molecular diagnostic service for migraine and related disorders, enabling precision diagnosis for thousands of patients. She drives national initiatives in genomics, population health and commercialisation. As founder of the Bridge and BridgeTech programs, she has transformed Australia’s biomedical innovation ecosystem to provide commercialisation training for the pharmaceutical and medical devices-technology fields. A passionate mentor and inspiration for women in STEMM, Professor Griffiths combines research excellence with strategic leadership to deliver real-world impact and strengthen national capacity.